Community Healthcare Trust (CHCT) to pay $0.40 on Mar 2, 2018; Prudential Financial Trimmed Astec Inds (ASTE) Stake

February 14, 2018 - By mmahotstuff

Prudential Financial Inc decreased Astec Inds Inc (ASTE) stake by 27.18% reported in 2017Q3 SEC filing. Prudential Financial Inc sold 33,350 shares as Astec Inds Inc (ASTE)’s stock declined 18.86%. The Prudential Financial Inc holds 89,357 shares with $5.00M value, down from 122,707 last quarter. Astec Inds Inc now has $1.38 billion valuation. The stock decreased 0.25% or $0.15 during the last trading session, reaching $59.64. About 118,383 shares traded. Astec Industries, Inc. (NASDAQ:ASTE) has risen 11.92% since February 14, 2017 and is uptrending. It has underperformed by 4.78% the S&P500.

Community Healthcare Trust Incorporated (NYSE:CHCT) is expected to pay $0.40 on Mar 2, 2018. $1.59 is the ADY. (NYSE:CHCT) shareholders before Feb 15, 2018 will receive the $0.40 dividend. Community Healthcare Trust Incorporated’s current price of $24.28 translates into 1.64% yield. Community Healthcare Trust Incorporated’s dividend has Feb 16, 2018 as record date. Feb 1, 2018 is the announcement. The stock decreased 0.08% or $0.02 during the last trading session, reaching $24.28. About 177,781 shares traded. Community Healthcare Trust Incorporated (NYSE:CHCT) has risen 34.78% since February 14, 2017 and is uptrending. It has outperformed by 18.08% the S&P500.

Among 4 analysts covering Community Healthcare Trust Incorporated (NYSE:CHCT), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Community Healthcare Trust Incorporated has $30.0 highest and $19.50 lowest target. $28.63’s average target is 17.92% above currents $24.28 stock price. Community Healthcare Trust Incorporated had 6 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Buy” rating by Sandler O’Neill on Wednesday, January 24. Evercore maintained the stock with “Buy” rating in Tuesday, September 8 report.

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in non-urban markets throughout the United States. The company has market cap of $427.79 million.

Among 9 analysts covering Astec Industries (NASDAQ:ASTE), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Astec Industries has $85 highest and $33 lowest target. $66.67’s average target is 11.79% above currents $59.64 stock price. Astec Industries had 18 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, August 31, the company rating was upgraded by Stifel Nicolaus. The stock of Astec Industries, Inc. (NASDAQ:ASTE) has “Buy” rating given on Tuesday, December 20 by Dougherty & Company. As per Tuesday, October 3, the company rating was maintained by Stifel Nicolaus. On Tuesday, October 20 the stock rating was maintained by Maxim Group with “Buy”. Robert W. Baird downgraded the stock to “Underweight” rating in Tuesday, July 19 report. The firm has “Outperform” rating given on Tuesday, January 2 by William Blair. The stock of Astec Industries, Inc. (NASDAQ:ASTE) has “Buy” rating given on Monday, May 16 by Maxim Group. Stifel Nicolaus maintained it with “Buy” rating and $7400 target in Wednesday, July 5 report. Robert W. Baird maintained Astec Industries, Inc. (NASDAQ:ASTE) rating on Thursday, January 4. Robert W. Baird has “Buy” rating and $70.0 target. The rating was downgraded by Dougherty on Wednesday, July 26 to “Neutral”.

Analysts await Astec Industries, Inc. (NASDAQ:ASTE) to report earnings on February, 20. They expect $0.45 EPS, down 15.09% or $0.08 from last year’s $0.53 per share. ASTE’s profit will be $10.38 million for 33.13 P/E if the $0.45 EPS becomes a reality. After $-0.12 actual EPS reported by Astec Industries, Inc. for the previous quarter, Wall Street now forecasts -475.00% EPS growth.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>